Catalyst Biosciences Inc buy stratec
Start price
08.12.17
/
50%
€3.48
Target price
19.01.18
€8.57
Performance (%)
146.76%
End price
19.01.18
€8.59
Summary
This prediction ended on 19.01.18 with a price of €8.59. With a performance of 146.76% the BUY prediction by stratec was a big success. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Catalyst Biosciences Inc | - | - | - | - |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% | 65.619% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% | 111.545% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% | 56.683% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% | 68.722% |
Comments by stratec for this prediction
In the thread Catalyst Biosciences Inc diskutieren
stratec stimmt der Buy-Einschätzung von melinda zu
stratec stimmt am 08.12.2017 der Buy-Einschätzung von melinda mit dem Kursziel 5,8$ zu.
Überschrift: pharma
- Catalyst Biosciences (NASDAQ:CBIO) initiated with Buy rating and $19 (166% upside) price target by B. Riley FBR.
(Vom Mitglied beendet)